Ziresovir, an antiviral drug targeted at respiratory syncytial virus (RSV), was superior to placebo in reducing signs and ...

DaxibotulinumtoxinA-lanm 500U showed the greatest reduction in MAS scores in patients suffering from spasticity following ...

In this randomized controlled trial, extended lymphadenectomy did not improve disease-free or overall survival in patients ...

In this randomized controlled trial, in patients with both moderate-severe obstructive sleep apnea (OSA) and obesity, it was ...

In this randomized controlled trial of men aged 50 to 60, forgoing prostate biopsies in those with elevated PSA but negative ...

In this randomized controlled trial, fidanacogene elaparovovec therapy significantly reduced the mean annualized rate of ...

In this randomized controlled trial, axatilimab effectively managed symptoms in patients with recurrent or refractory graft ...

Serious adverse events were comparable between both groups. Evidence Rating Level: 1 (Excellent) Study Rundown: Inoperative ...

In this cluster-randomized controlled trial, in communities with a high rate of opioid-related overdoses, the implementation ...

This follow-up analysis of the phase 3 REPRIEVE trial demonstrated that region of residence, prediabetes, high BMI, and ...

In this randomized controlled trial, among patients with moderately to severely active ulcerative colitis, tulisokibart, a ...

In a cluster randomized clinical trial, electronic health record (EHR)-based intervention increased the frequency of ...